Canlyniadau Chwilio - Lida Bubuteishvili‐Pacaud
- Dangos 1 - 4 canlyniadau o 4
-
1
Everolimus in advanced, progressive, well-differentiated, non-functional neuroendocrine tumors: RADIANT-4 lung subgroup analysis gan Nicola Fazio, Roberto Buzzoni, Gianfranco Delle Fave, Margot Tesselaar, Edward M. Wolin, Eric Van Cutsem, Paola Tomassetti, Jonathan Strosberg, Maurizio Voi, Lida Bubuteishvili‐Pacaud, Antonia Ridolfi, Fabian Herbst, Jiří Tomášek, Simron Singh, Marianne Pavel, Matthew H. Kulke, Juan W. Valle, James C. Yao
Cyhoeddwyd 2017Artigo -
2
A randomized, open-label, phase 2 study of everolimus in combination with pasireotide LAR or everolimus alone in advanced, well-differentiated, progressive pancreatic neuroendocrin... gan Matthew H. Kulke, Philippe Ruszniewski, Eric Van Cutsem, Catherine Lombard‐Bohas, Juan W. Valle, Wouter W. de Herder, Marianne Pavel, Evgeny Degtyarev, Jan C. Brase, Lida Bubuteishvili‐Pacaud, Maurizio Voi, Ramón Salazar, Ivan Borbath, Nicola Fazio, Denis Smith, Jaume Capdevila, Rachel P. Riechelmann, Jin‐Guang Yao
Cyhoeddwyd 2017Artigo -
3
Everolimus in Neuroendocrine Tumors of the Gastrointestinal Tract and Unknown Primary gan Simron Singh, Carlo Carnaghi, Roberto Buzzoni, Rodney F. Pommier, Markus Raderer, Jiří Tomášek, Harald Lahner, Juan W. Valle, Maurizio Voi, Lida Bubuteishvili‐Pacaud, Jeremie Lincy, Edward M. Wolin, Natsuko Okita, Steven K. Libutti, Do‐Youn Oh, Matthew H. Kulke, Jonathan Strosberg, James C. Yao, Marianne Pavel, Nicola Fazio
Cyhoeddwyd 2017Artigo -
4
Health-related quality of life for everolimus versus placebo in patients with advanced, non-functional, well-differentiated gastrointestinal or lung neuroendocrine tumours (RADIANT... gan Marianne Pavel, Simron Singh, Jonathan Strosberg, Lida Bubuteishvili‐Pacaud, Evgeny Degtyarev, Maureen P. Neary, Carlo Carnaghi, Jiří Tomášek, Edward M. Wolin, Markus Raderer, Harald Lahner, Juan W. Valle, Rodney F. Pommier, Eric Van Cutsem, Margot Tesselaar, Gianfranco Delle Fave, Roberto Buzzoni, Matthias Hünger, Jennifer Eriksson, David Cella, Jean‐Francois Ricci, Nicola Fazio, Matthew H. Kulke, James C. Yao
Cyhoeddwyd 2017Artigo
Offerynnau Chwilio:
Pynciau Perthynol
Clinical endpoint
Everolimus
Internal medicine
Medicine
Adverse effect
Alternative medicine
Confidence interval
Gastroenterology
Hazard ratio
Pathology
Placebo
Randomized controlled trial
Neuroendocrine tumors
Oncology
Surgery
Acromegaly
Chemotherapy
Clinical trial
Discontinuation
Growth hormone
Hormone
Nursing
Pasireotide
Progressive disease
Quality of life (healthcare)
Subgroup analysis
Urology